On Friday, Gossamer Bio Inc (NASDAQ: GOSS) was 17.13% up from the session before settling in for the closing price of $2.51. A 52-week range for GOSS has been $0.66 – $2.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 40.29% over the past five years. When this article was written, the company’s average yearly earnings per share was at -167.09%. With a float of $182.70 million, this company’s outstanding shares have now reached $227.32 million.
Gossamer Bio Inc (GOSS) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Gossamer Bio Inc stocks. The insider ownership of Gossamer Bio Inc is 19.65%, while institutional ownership is 61.54%. The most recent insider transaction that took place on Aug 19 ’25, was worth 50,016. In this transaction Director of this company bought 26,050 shares at a rate of $1.92, taking the stock ownership to the 58,050 shares.
Gossamer Bio Inc (GOSS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -167.09% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.92% during the next five years compared to 40.29% growth over the previous five years of trading.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
You can see what Gossamer Bio Inc (GOSS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.61, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.48 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
Gossamer Bio Inc (NASDAQ: GOSS) saw its 5-day average volume 4.9 million, a positive change from its year-to-date volume of 2.1 million. As of the previous 9 days, the stock’s Stochastic %D was 80.69%.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 98.18%, which indicates a significant increase from 96.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.19 in the past 14 days, which was higher than the 0.13 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.87, while its 200-day Moving Average is $1.26. Nevertheless, the first resistance level for the watch stands at $3.11 in the near term. At $3.28, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.58. If the price goes on to break the first support level at $2.64, it is likely to go to the next support level at $2.34. Assuming the price breaks the second support level, the third support level stands at $2.17.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
There are 227,381K outstanding shares of the company, which has a market capitalization of 668.50 million. As of now, sales total 114,700 K while income totals -56,530 K. Its latest quarter income was 11,490 K while its last quarter net income were -38,270 K.
